arthritis
Clinical tips: osteoarthritis
It may be time to change your thinking about osteoarthritis, writes Ben Basger Osteoarthritis is the leading musculoskeletal cause of disability in Western society. It is the most common form …
Reconsider Panadol Osteo delisting in light of risks: Painaustralia
The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …
Why pharmacists need to change their thinking
The expanding role of community pharmacists—from making medicines to optimising outcomes—will require a shift in thinking, writes Vanessa Lontos Recently the International Pharmaceutical Federation (FIP), whose role is to advance …
Knee and back pain review needed following waste revelations
Arthritis Australia is calling for an urgent review of care arrangements for people with knee and back pain following a Four Corners report that millions of health dollars are being …
Rheumatoid arthritis treatment in new class of medicines
A new oral treatment alternative for patients with moderate to severe rheumatoid arthritis, will be available on the PBS from 1 October, 2015.
Back pain and arthritis costs more than $14 billion
Research published in the Medical Journal of Australia today confirms that lost productivity due to back pain and arthritis currently costs Australia more than $14 billion a year and will …
Arthritis patients may be mismanaging paracetamol
Many Australians with arthritis may be putting their health at risk by inadvertently mismanaging the amount of paracetamol medications they consume, new research has found – and pharmacists can help …
All placebos aren’t created equal
All placebos aren’t created equal: the way they’re delivered can make a difference in how patients respond to the sham therapy, new research has found. A systematic evidence review published …
Most arthritis sufferers have comorbidities: AIHW
New information released today by the Australian Institute of Health and Welfare shows that about three quarters of people with arthritis are also affected by at least one other chronic …
Don’t give pharmacists power over biosimilars: Australian Rheumatology Association
The Australian Rheumatology Association has expressed concerns about risks to patient safety it says could follow from measures on biosimilars going through the Senate today as part of the wider …
1 in 7 affected by arthritis
New AIHW data shows that about 3.3 million Australians, or one in every seven people reported having some form of arthritis in 2011-12. The release is part of the Institute’s …
Chondroitin benefits confirmed
The Australian Self Medication Industry has welcomed new research that confirmed the benefits of chondroitin sulphate for osteoarthritis. A Cochrane Review of 9,110 people across 43 randomised controlled studies revealed …